Concepedia

Peter Zuidewind

PZ

Statistics

Publications

5

Citations

6.2K

H-Index

5

Active since

2018

Affiliations

Stellenbosch University(Current)

University College London

University of the Witwatersrand

Perinatal HIV Research Unit

University of Oxford

Peter Zuidewind is an author at Stellenbosch University specializing in disease classification, epidemiology, and hiv.

ORCID

Top concepts

Publications per year

2018–2022

5

Publications

5

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Strong sex bias in elite control of paediatric HIV infection

Vinícius Vieira, Peter Zuidewind, Maximilian Muenchhoff et al. · AIDS · 2018 · 32 citations · Full text

Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS

Sara Domínguez‐Rodríguez, Miquel Serna‐Pascual, Andrea Oletto et al. · PLoS ONE · 2022 · 28 citations · Full text

, , +14

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 23 citations · Full text

1–5 of 5